Michelle Dipp, co-founder and managing partner at Biospring Partners (via Michelle Dipp's website)
April 14, 2022 11:44 AM EDT
Manufacturing

Q&A: Biospring co-founder ex­plains re­cent in­vest­ment in San Diego CD­MO

Josh Sullivan

Ear­li­er this week, the San Diego CD­MO Abzena land­ed a $65 mil­lion in­vest­ment to ex­pand its drug sub­stance and fill-fin­ish ca­pac­i­ty. Part of that in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times